|     home    |     search     |     content     |     mail     |     login     |
studies of SHM (46) which were not included in the Bolder project

with reason for exclusion.

211923471-5-2001Timing of human immunodeficiency virus type 1 and human herpesvirus 8 infections and length of the Kaposi's sarcoma-free period in coinfected persons.
reason:
210393055-1-2001Cross-staining of cytotoxic T lymphocyte populations with peptide-MHC class I multimers of natural HIV-1 variant antigens.
reason:
210393095-1-2001The ADAM study continued: maintenance therapy after 50 weeks of induction therapy.
reason:
2043692228-7-2000Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine.
reason:
2034957212-7-2000Quality of life in maintenance vs prolonged induction therapy for HIV.
reason:
203839837-7-2000A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration.
reason:No Cohort
203839867-7-2000A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients.
reason:No Cohort
203520071-7-2000T-cell progenitor function during progressive human immunodeficiency virus-1 infection and after antiretroviral therapy.
reason:
2035076816-6-2000Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.
reason:
2035078116-6-2000Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir.
reason:
2031101826-5-2000The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals.
reason:
202963975-5-2000Decreased exposure to saquinavir in HIV-1-infected patients after long-term antiretroviral therapy including ritonavir and saquinavir.
reason:
2023131210-3-2000The effect of treatment intensification in HIV-infection: a study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine. Prometheus Study Group.
reason:
2017058328-1-2000Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. The Prometheus Study Group.
reason:
200441271-10-1999An enzymatic synthesis of glucuronides of azetidinone-based cholesterol absorption inhibitors.
reason:No Cohort
201467031-1-1999Retroviruses et opportunistic infections '99.
reason:
990710451-11-1998Incidence and risk factors of diarrhoea in Dutch travellers: consequences for priorities in pre-travel health advice.
reason:No Cohort
991235411-8-1998Lack of efficacy of low dose oral interferon alfa in symptomatic HIV-1 infection: a randomised, double blind, placebo controlled trial.
Title DutchNo Cohort
reason:
201884841-1-1998Strategies for rescue therapy.
reason:
983445851-1-1998Clinical trials in Asia.
reason:

displaying records 1 to 20 of 46


  • click on a studycode to view more details
  • click on "all studies" to view a list of all studies for this institute
  • click on "included studies" to view a list of all studies for this institute that were included in the Bolder project.
  • if not all records are displayed, click on 'display all records' to view them all
  • click on the back button to go to the previous screen